
zzso can be recognized by the immune system, and the immune system may regulate and even eliminate zzso The development of checkpoint blocking zzso such as those directed against zzso zzso zzso 4 zzso and programmed death 1 zzso zzso have demonstrated significant recent promise in the treatment of an expanding list of zzso While both zzso and zzso function as negative regulators, each plays a zzso role in modulating immune zzso zzso zzso the early zzso of zzso and memory T zzso In contrast, zzso is primarily involved in modulating T cell activity in peripheral zzso via interaction with its zzso zzso and zzso Unfortunately, not all patients respond to these therapies, and evaluation of zzso associated with clinical outcomes is zzso This review will examine the zzso zzso and clinical development of checkpoint blocking zzso including agents already approved by the US Food and Drug Administration zzso zzso or in development zzso zzso Future studies will likely uncover new promising zzso checkpoints to target alone or in combination with other zzso approaches, chemotherapy, zzso and small zzso 

